Evidence That Stem Cell Factor Is Involved in the Rebound Thrombocytosis That Follows 5-Fluorouracil Treatment

Autor: Hunt, Pamela, Zsebo, Krisztina M., Hokom, Martha M., Hornkohl, Alex, Birkett, Neal C., del Castillo, Juan C., Martin, Francis
Zdroj: Blood; August 1992, Vol. 80 Issue: 4 p904-911, 8p
Abstrakt: The mechanisms responsible for 5-fluorouracil (5FU)-induced rebound thrombocytosis are not completely understood. SI/SIdmice, which do not undergo rebound thrombocytosis in response to 5FU, provide a genetic approach to the study of this phenomenon. Recent reports by several groups that the SIlocus encodes a protein known variably as stem cell factor (SCF), mast cell growth factor, or kitligand, suggests the possibility that the lack of wild-type SCF in SI/SIdmice is responsible for their defective response to 5FU-induced thrombocytopenia. It is shown in this report that SCF-treated SI/SIdmice are as capable as their wild-type littermates in undergoing rebound thrombocytosis. W/Wvmice, mutated at the locus encoding the SCF receptor, also do not undergo rebound thrombocytosis, but are not responsive to SCF treatment. In normal mice, it is shown by RNA solution hybridization that SCF mRNA expression is increased during the 5FU-induced platelet nadir period. It is also shown by autoradiography that maturing megakaryocytes express SCF receptors, and that in vivo administration of SCF significantly raises the numbers of megakaryocytes, as well as circulating platelet counts. Taken together, these data indicate that SCF may be an important regulator of platelet production under both normal and physiologically disturbed situations.
Databáze: Supplemental Index